Australian Investor
home page boresight
WDS$29.92
-3.30%
TLS$5.17
+0.98%
STO$8.45
-4.20%
PLS$2.62
-8.39%
FMG$13.44
-9.49%
CBA$169.92
-0.56%
CSL$197.29
-2.77%
BHP$51.40
-12.67%
SQ2$95.20
-0.55%
WDS$29.92
-3.30%
TLS$5.17
+0.98%
STO$8.45
-4.20%
PLS$2.62
-8.39%
FMG$13.44
-9.49%
CBA$169.92
-0.56%
CSL$197.29
-2.77%
BHP$51.40
-12.67%
SQ2$95.20
-0.55%
Back to Articles
fundraising
NOX
Offer Open

Noxopharm Raises $1.5 Million to Accelerate Clinical Programs

Biotech firm Noxopharm has secured $1.5 million via a placement and announced plans for a $1.0 million SPP.

November 4, 2026
Share:
Noxopharm Raises $1.5 Million to Accelerate Clinical Programs

Biotechnology company Noxopharm has successfully raised $1.5 million through a placement to propel its SOF-SKN clinical program. In addition to the placement, the company plans to launch a $1.0 million Share Purchase Plan (SPP) and has converted $3.78 million in notes to further accelerate its drug development pipeline.

Capital Raise
Biotech
Noxopharm